Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and other bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for constructing complex nitrogen-containing heterocycles. The compound's stereochemistry and fluorinated aryl group enhance binding affinity and metabolic stability in drug candidates. It is primarily employed in research settings for optimizing lead compounds in treatments targeting viral infections and central nervous system disorders.